James J. Hsieh, MD, PhD, discusses unmet needs in non-clear cell renal cell carcinoma.
James J. Hsieh, MD, PhD
Advertisement
Articles by James J. Hsieh, MD, PhD
James J. Hsieh, MD, PhD, medical oncologist, Memorial Sloan Kettering Cancer Center, gives an overview of emerging treatments for patients with kidney cancer.
Advertisement
Latest Updated Articles
Dr. Hsieh on Unmet Needs of Rare Kidney Cancer VariantsOctober 4th 2019
Dr. Hsieh Discusses New Treatments for Kidney CancerApril 25th 2014
Advertisement
Advertisement
Trending on OncLive
1
Ifinatamab Deruxtecan BLA Voluntarily Withdrawn in Previously Treated Extensive-Stage SCLC
2
FDA Approves Lirafugratinib for Pretreated, Locally Advanced or Metastatic Cholangiocarcinoma
3
Long-Term PERSEUS Data Confirm Durable PFS Benefit With D-VRd in Transplant-Eligible Newly Diagnosed Myeloma
4
FDA Grants Priority Review to Perioperative Durvalumab Plus Neoadjuvant Enfortumab Vedotin in MIBC
5